Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Indazole inhibitors of PDE IV and TNF from Pfizer

March 18, 1998

Lilly develops selective serotonergic agents

March 18, 1998

Sumitomo claims compounds for treating reperfusion injury

March 18, 1998

Ono's new MMP inhibitors

March 18, 1998

Novartis describes new thrombin inhibitors

March 17, 1998

Neuroprotective glutamate antagonists from Warner-Lambert

March 17, 1998

Glaxo Wellcome researches MMP inhibitors

March 17, 1998

Depsipeptides useful in dementia under evaluation at Nisshin Flour Milling

March 17, 1998

Improved agents for schizophrenia developed at Yoshitomi

March 17, 1998

Nikken Chemicals develops new agents for asthma

March 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...